Cytokinetics, Incorporated ( CYTK) - Key Metrics
CYTK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.24 | -$1.50 | -$1.21 | -$1.24 |
| 2026Q1 | $0.16 | -$1.67 | -$1.18 | -$1.23 |
| 2025Q4 | $0.15 | -$1.50 | -$1.17 | -$1.22 |
| 2025Q3 | $0.02 | -$2.55 | -$0.90 | -$0.97 |
| 2025Q2 | $0.56 | -$1.12 | -$1.07 | -$1.11 |
CYTK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -14.20 |
| 2026Q1 | 0% | -9.87 |
| 2025Q4 | 0% | -10.66 |
| 2025Q3 | 0% | -5.39 |
| 2025Q2 | 0% | -7.37 |
CYTK
Price: $74.13
52 week price:
Earnings Per Share: -7.14 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 998300
Ebitda: -35.8 millionMarket Capitalization: 10.5 billion